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ne Schwano « 11s Bnd fibroblast-lIke cells oe tbe iatBet seiatie 
Bene oe adult rats syathalze very little nerve growth (actoT (NGF) 
(nr. I). After IHion, bOll"cver, tben Is a dramatk increase in tbe 
.mounts oe botb NGF-mRNA and NGF proteia syothesized by 
lhe seistle nOD-neuronal cells!,l, TbilJ locallncrease in NGF sr.-
thesis partlally replaces the loterrupted NGF supply (rom the 
periphery 10 the NGF-respoDsive 5eOSOI')' u d sympathetlc neurons, 
wbose axODS ruD "ithln the sclatk nene!. Macrophages, Down 
10 lovade tbe slte of Mn" lesion during wallerian dqeoeratlooJ.· , 
are import.nt in the regulation oe NGF synthesiS'. Here we demon-
stnte ebat tbe efl'ect of maeropbage5 on NGF-mRNA levels In 
cultured explants of sei.eie oerve C&n be mimieked by condltioned 
media of actl"ated macrophages, aad that iDterleukio-t Is the 
responsible agent. 
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Flg_ I a, Changes in NGF_mRNA levels of ral sciaüc nerve 
segmenu by condi tioned media of aClivated rat macrophages. b, 
TIme course of induetion by IL-Iß. Human recombinant IL-Iß 
(30 U mI- I) of spedfic aetivily 4 )( Hf U I1g- 1 protein was used. 
The dashed line shows the eHeet of re ·addition of IL-Iß to cuhures 
incubated 12 h with the protein. C, IL-Iß dose-response curve for 
NGF-mRNA induetion. The incubation was for Ihree hours and 
averages of two determinalions at each concentration are given. 
Melhods. Seiatic nerve segments (3 cm) of adult Wistar rats were 
culturc:d in I ml Dulbeeco's modi lied Eagle's medium supple-
mented with 10% feta l calfserum. After th ree days culturc, medium 
conditioncd by either rat peritoneal macrophages or human recom-
binant IL- Iß was added. Rat periloncal macrophagc:s were purified 
by allachment to plastic, and activated with lipopolysaccharide 
(LPS) (Sigma) for 20 h (10 I-I-g ml- L). Media eonditioned by the 
adherent cells with more than 95% macrophages, as evalualed by 
the speeific anlibody EDI (ref. 17), wert eolleeted and added to 
the nerve explant cultures. NG F-mRNA was determined by a quan-
titat ive Northern blot procedure, using a calibration standard (0.92 
ki lobases (kb» for NGF-mRNA (rtf. 16). The recovery o f RNA 
was estimated using a shorter NGF-mRNA transcript (0 .5 1 kb), 
whieh was added 10 the tissue sampies before RNA euraetion'6. 
The aUloradiograms were quantified 0 0 a scaoning densitometer 
for the amouot of NGF-mRNA preseot. Valucs are expressed as 
fg per mg wet weight of ti ssue, and they represeot mean "'s.d. of 
three or more separate detenninalion$. The open eirdes represent 
the conlrol values of n~rve segments incubated fo r 24 h. 
In previous experimenls we have shown that although the 
lesion-mcdiated incrcase in NGF-m RNA is biphasic in vivo L, 
in cultures of rat sciatic nerve thefe was only a rapid a nd t ransient 
increase in NGF-mRNA, which was not fo llowed by the chronic 
rise observed in vivo ~. The addition o f activat~d macrophages 
to the cul ture system resulted in increase of sciatic NGF-mRNA 
comparable to that obse rved in vivo5• To decide wheth er these 
effects result from cell- cell conlact or are mediated by a humoral 
faclor, we prepared m~dia conditioned by activated rat 
macrophages. Figure I shows that rat sciatic nerve segments 
cultured for three days contained only relatively low a mounts 
of NGF-mRNA which were markedly (I I -fold) enhanced when 
the cultur~s were supplemented b y macrophage-con d ilioned 
m~dia , to reach a stabl~ m aximum after three ho urs. Of the 
many biologically aetive m oleeules synth~sized by activat~d 
macro phages'. prostagiandin El , a nd acidic a nd basic fib ro blast 
growth factor ( FGF) did not aITeet the amount of NGF-mR NA 
















Agents were added to sciatic nerve segments after culture for three 
days. Afler incubation for three hours, sciatic NGF-mRNA was quanti-
tated u described in Fig. I legend. Prostagiandin E1 (Sigma) was uscd 
at a final concentration of 5 ~M (ref. 18); acidic and basic FGF (a gift 
rrom Dr Sensenbrenner'9) were at a concentration of 5 ng mi - I. PDGF 
(Speywood, UK) was used at a concentration of 3 U ml- ' (ref. 20). 
Human TNF-a (eacheetin; Amgen. Amersham) was used at a final 
concentration of 1,000 U mI- I (ref. 2 \ ). These concentrations are com-
parable to Ihose known to produce a maximal effect. Values reprcsent 
the average of (WO or more separate deterrninations. 
produced (Table I ). Tumour neerosis factor (TNF) and platelet-
derived growth factor (POGF), whieh are major eonstituents of 
maerophage-eonditioned media7 , doubled the amounl of NGF-
mRNA presenl. But the addition of recombinant human inter-
leukin-Iß (IL.- Iß ) (ref. 8) resulted in a 14-fold inerease in NGF-
mRNA (Fig.lb). The effect of IL-I ,8 was diseemible at a con-
centration of 1 U mi- I and was maximal at about 10 U mi- I. No 
difference was seen between the effeets of recombinant IL- l a 
and IL.-l,8 whieh are both produeed by activated macrophages9 , 
supporting the view that these structurally different molecules 
(the homology between human and murine IL-Ia and IL.-I ß is 
only 30% 10 _12 ) have similar biological activities. Tbe eflects of 
human IL-I and rat macrophage-eonditioned medium on NGF-
mRNA are similar, both with respeci 10 the extenl and the 
time-course of the increase. Re-addition of IL-I ß after 12 hOU TS 
resulted in a repeat inerease in NG F-mRNA tOlhe level observed 
after the first addition, indicaling that Ihe protein was either not 
stable, or was degraded by the sciatic explants. 
Because antibodies to rat IL-I were not available, we used 
conditioned media of human macrophages, which aHected the 
amounts ofrat sciatic nerve NGF-mRNA produced to the same 
extent as the rat medium. The inerease in NGF-mRNA observed 
after addition of recombinant IL-I and human macrophage-
derived medium could bolh be inhibited to the same extent by 
specific polyclonal anlibodies to human IL-I (Fig.2). Thus, 
most, if not all , of the aelivity of the human macrophage-
conditioned medium is due 10 IL-t. It is probable Ihat the same 
is true for the eonditioned medium of rat maerophages, allhough 
direct proof is not yel possible due to the unavailability of 
antibodies to rat IL· I and 10 the poor interspecies immunological 
cross_reactivityll. Our interpretation is supported by the associ-
at ion ofthe activity ofthe rat-conditioned medium with fraetions 
of relative moleeular mass (M,) between 10,000-20,000 (10-
20K) (data not shown). 
These results could explain the in vivo and the in vitro dis-
crepancys; in virf"O, macrophages must be added to simulate the 
ehronie inerease in NGF-mRNA whieh occurs after lesion in 
vivo, and which remains high for more than two weeks '·'. Fol -
lowing a peripheral nerve injury, maerophages invade the si te 
of lesion1 •4 to stimulate eoncomitant increase in NGF-mRNA 
levels'. These observations combined witb OUTS indicale that 
macrophages are responsible for the persistent increase in NGF 
in the injured nerve in vivo. Note that macrophages themselves 




< z 200 • ,
" ~ z 
o .L.L...Ll-
Con lrOI H-l Medium 
Fig. 2 Effcct of macrophage_conditioned medium on sciatic 
NG F-mRNA; blockade by antibodies to 1L- 1. Condilioned media 
derived from LPS·aclivated human peritoneat macrophagcs were 
diluted 1 10 20 and used in the ral nerve explant cullures (see 
Fig. I ). Apart of the medium was prctreatcd with rabbit antibodies 
raised again$! human fL-l before adding it 10 the culturc system. 
As a control 30 U of human recombinant lL·\ was treated similarly 
and then added to ellplant cultures. The antibodics used werc 
polyvalent (Gen:.:yme, Boston). Following incubation for Ihree 
hours, the amounts of sciatic NGF-mRNA present were deter-
mincd as described in Fig. I legend. The open bars show the results 
of incubating the nerve pieees with IL-I or with the buman 
macrophage-conditioned medium; tbe hatehed bars represenl 
resulls after prelrcalmcnl oflhe medium or of 11..-\ Wilh the specifie 
antibodies. Thc valu ~s represent mean ±s.d. of three independent 
delerrninations. 
to the amount of NGF present is indirect and mediated mainly 
by IL-1. 
Macrophages and the IL.-l they release could also be impor-
tant in the regulation of NGF synthesis during normal develop-
ment; the amount of NGF~mRNA in the sciatic nerve of 
newbom ra ts is comparable to that in lesioned adult nerves ' , 
and decreases to adult values by the thi rd postnatal week~, by 
whieh time the high density of macrophages in the newbom rat 
sciatic nerve has also decreased to the low intaet adult nerve 
levels·. Intereslingly, TL-I aetivity has also been detected in the 
central nervous system following brain injuryl\ but cellular site 
of synthesis has not yel been established ' l •1S• 
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